Advertisement

Topics

Search Results for "Recall Promus Heart Stent"

03:35 EDT 2nd July 2016 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

Paclitaxel-eluting balloons reduce late lumen loss in coronary in-stent restenosis

In the prospective, randomized Treatment of In-Stent Restenosis study, use of paclitaxel-eluting balloons to treat bare metal stent restenosis yielded lower rates of late lumen loss at 12 months compa...

FDA Advisors Question Abbott's Dissolving Heart Stent

Abbott Labs is seeking FDA approval to sell a novel coronary stent that dissolves after it is implanted, but government scientists have raised questions about potential heart attack and blood clots ri...

FDA Advisers Question Abbott's Dissolving Heart Stent

Abbott Labs is seeking FDA approval to sell a novel coronary stent that dissolves after it is implanted, but government scientists have raised questions about potential heart attack and blood clots ri...

Health Highlights: March 16, 2016

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: FDA Panel Recommends Approval of Dissolving Heart Stent A dissolving heart stent should be appro...

FDA panel backs Abbott's dissolving heart stent

March 15 (Reuters) - FDA ADVISORY PANEL VOTES 9-0 IN FAVOR OF ABBOTT'S DISSOLVING HEART STENT (Reporting by Susan Kelly in Chicago)

Women undergoing PCI with newer DES have higher prevalence of chest pain

In a pooled analysis of the DUTCH PEERS and TWENTE randomized trials, the prevalence of clinically relevant chest pain was significantly higher among women undergoing PCI with newer-generation drug-el...

Update: Tippin's Gourmet Pies, LLC Announces the Recall of Tippin's Key Lime Pie for the Presence of Undeclared Peanut Residue Due to Supplier Recall

In the June 17, 2016 recall announcement, lot numbers 04-07-16 and 04-14-16 were originally listed as part of the recall. We have since learned that the above lot numbers are not affected by the recal...

FDA advisers to weigh risks of Abbott’s dissolving stent

(Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after ...

Matching PubMed Articles

Investigation of fibrous cap stresses on vulnerable plaques leading to heart attacks.

Rupture-prone plaques in the coronary arteries, called ``vulnerable plaques'', are recognized as the key factor in acute myocardial infarction. Vulnerable plaques have a thin fibrous cap over a large ...

Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.

Fibrin deposition and absent endothelium characterize unhealed stents that are at heightened risk of stent thrombosis. Optical coherence tomography (OCT) is increasingly used for assessing stent tissu...

Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.

Drug-eluting stents (DES) reduce restenosis, as compared with bare-metal stents (BMS); however, the relationship between stent type and health status is unknown. We examined whether stent type was ass...

Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.

In-stent restenosis (ISR) remains an important concern despite the recent advances in the drug-eluting stent (DES) technology. The introduction of drug-eluting balloons (DEB) offers a good solution to...

Impact of Neointimal Calcifications on Acute Stent Performance during the Treatment of In-Stent Restenosis.

Optical coherence tomography (OCT) has become the invasive imaging modality of choice for coronary stent assessment due to its unmatched spatial resolution. Neointimal calcification (NC) is a rare fin...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement